title: Open-Label Trial of MABp1, a True Human Monoclonal Antibody Targeting Interleukin 1α, for the Treatment of Psoriasis.
authors.affiliation: Westlake Dermatology and Cosmetic Surgery, Austin, Texas.
authors.forename: Kyle M
authors.initials: KM
authors.lastname: Coleman
authors.affiliation: Department of Dermatology, University of Michigan, Ann Arbor.
authors.forename: Johann E
authors.initials: JE
authors.lastname: Gudjonsson
authors.affiliation: XBiotech USA, Austin, Texas.
authors.forename: Michael
authors.initials: M
authors.lastname: Stecher
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000097:blood / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006207:Half-Life; D006801:Humans; D007279:Injections, Subcutaneous; D053582:Interleukin-1alpha / Q000378:metabolism*; D011565:Psoriasis / Q000188:drug therapy* / Q000378:metabolism*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D053582:Interleukin-1alpha; C000599944:MABp1 monoclonal antibody